C
Cristal Therapeutics
Targeted nanomedicines for cancer treatment
About Cristal Therapeutics
Cristal Therapeutics is a clinical-stage pharmaceutical company focused on developing advanced nanomedicines for the treatment of cancer and other diseases with significant unmet medical needs. The company operates in the life sciences and pharmaceutical markets, targeting both patients and healthcare providers who require innovative treatment options.
Cristal Therapeutics leverages two main proprietary platforms: CriPec and CliCr. The CriPec technology platform uses polymers to design and manufacture custom-made nanomedicines. These nanomedicines can be tailored for new drug candidates or existing market drugs, enhancing their effectiveness and safety profiles. The CliCr platform offers a copper-free click chemistry reagent, which is a tool used in the life sciences industry to facilitate the development of new drugs without the toxicity associated with copper-based reagents.
The company primarily serves the oncology sector, aiming to develop the next generation of cancer treatments. However, its technology also has applications in other therapeutic areas with high commercial potential. Cristal Therapeutics generates revenue through partnerships, licensing agreements, and potentially through the commercialization of its proprietary nanomedicines once they receive regulatory approval.
Cristal Therapeutics' business model is built on innovation and collaboration. By partnering with other pharmaceutical companies and research institutions, it aims to bring its advanced nanomedicine solutions to market more efficiently. The company’s experienced leadership team combines expertise in scientific research, clinical development, and business strategy, positioning Cristal Therapeutics as a key player in the pharmaceutical industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Maastricht, Netherlands
- Employees
- 4
- Open positions
- None listed
- Dealroom signal
- 74.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Biomedical, Spinout, Biotech and Pharma, Horizon Europe, DT and LS, science-based
- Technology
- Nanotech
- Business model
- Manufacturing
- Client focus
- B2B
Knowledge graph
News
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Nov 2017 | $2.8M | — | European Commission | — |
| GRANT✓Other financing | Jul 2017 | $2.8M | — | European Innovation Council | — |
Growth signals
Latest recorded traffic for Cristal Therapeutics is 1.7K monthly website visits, up 254.2% over the last three months. Cristal Therapeutics's team grew 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Cristal Therapeutics in the Maastricht ecosystem
The Cristal Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
European Innovation Council
European Commission
Series A8 investors entered at this stage
BioGeneration Ventures
Chemelot Ventures
Thuja Capital
Aglaia BioMedical Ventures
Droia Oncology Ventures
Utrecht University
LIOF - Limburg Regional Development Agency
BOM - Brabant Regional Development Agency
Other known investors6 additional known investors
Brightlands Maastricht Health Campus
Brightlands Venture Partners
LifeSciences@work
Limburg Business Development Fonds
Utrecht Holdings
UtrechtInc
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cristal Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cristal Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.